Global Glucagon Market Overview And Scope:
Global Glucagon Market Size was estimated at USD 556.9 million in 2022 and is projected to reach USD 797.2 million by 2028, exhibiting a CAGR of 6.16% during the forecast period.
The Global Glucagon Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Glucagon utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals
Global Glucagon Market Segmentation
By Type, Glucagon market has been segmented into:Inject Glucagon
Nasal Glucagon
By Application, Glucagon market has been segmented into:
Emergency Kits
General Use
Diagnostic and Motility
Cardiogenic Shock
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Glucagon market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Glucagon market.
Top Key Players Covered in Glucagon market are:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Objective to buy this Report:
1. Glucagon analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Glucagon market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Glucagon Market by Type
5.1 Glucagon Market Overview Snapshot and Growth Engine
5.2 Glucagon Market Overview
5.3 Inject Glucagon
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Inject Glucagon: Geographic Segmentation
5.4 Nasal Glucagon
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Nasal Glucagon: Geographic Segmentation
Chapter 6: Glucagon Market by Application
6.1 Glucagon Market Overview Snapshot and Growth Engine
6.2 Glucagon Market Overview
6.3 Emergency Kits
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Emergency Kits: Geographic Segmentation
6.4 General Use
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 General Use: Geographic Segmentation
6.5 Diagnostic and Motility
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Diagnostic and Motility: Geographic Segmentation
6.6 Cardiogenic Shock
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Cardiogenic Shock: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Glucagon Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Glucagon Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Glucagon Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NOVO NORDISK
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ELI LILLY
7.4 FRESENIUS KABI
7.5 TORRENT LABS
7.6 TAJ PHARMACEUTICALS
7.7 XERIS PHARMACEUTICALS
Chapter 8: Global Glucagon Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Inject Glucagon
8.2.2 Nasal Glucagon
8.3 Historic and Forecasted Market Size By Application
8.3.1 Emergency Kits
8.3.2 General Use
8.3.3 Diagnostic and Motility
8.3.4 Cardiogenic Shock
8.3.5 Others
Chapter 9: North America Glucagon Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Inject Glucagon
9.4.2 Nasal Glucagon
9.5 Historic and Forecasted Market Size By Application
9.5.1 Emergency Kits
9.5.2 General Use
9.5.3 Diagnostic and Motility
9.5.4 Cardiogenic Shock
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Glucagon Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Inject Glucagon
10.4.2 Nasal Glucagon
10.5 Historic and Forecasted Market Size By Application
10.5.1 Emergency Kits
10.5.2 General Use
10.5.3 Diagnostic and Motility
10.5.4 Cardiogenic Shock
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Glucagon Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Inject Glucagon
11.4.2 Nasal Glucagon
11.5 Historic and Forecasted Market Size By Application
11.5.1 Emergency Kits
11.5.2 General Use
11.5.3 Diagnostic and Motility
11.5.4 Cardiogenic Shock
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Glucagon Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Inject Glucagon
12.4.2 Nasal Glucagon
12.5 Historic and Forecasted Market Size By Application
12.5.1 Emergency Kits
12.5.2 General Use
12.5.3 Diagnostic and Motility
12.5.4 Cardiogenic Shock
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Glucagon Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Inject Glucagon
13.4.2 Nasal Glucagon
13.5 Historic and Forecasted Market Size By Application
13.5.1 Emergency Kits
13.5.2 General Use
13.5.3 Diagnostic and Motility
13.5.4 Cardiogenic Shock
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Glucagon Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Inject Glucagon
14.4.2 Nasal Glucagon
14.5 Historic and Forecasted Market Size By Application
14.5.1 Emergency Kits
14.5.2 General Use
14.5.3 Diagnostic and Motility
14.5.4 Cardiogenic Shock
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Glucagon Scope:
|
Report Data
|
Glucagon Market
|
|
Glucagon Market Size in 2025
|
USD XX million
|
|
Glucagon CAGR 2025 - 2032
|
XX%
|
|
Glucagon Base Year
|
2024
|
|
Glucagon Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals.
|
|
Key Segments
|
By Type
Inject Glucagon
Nasal Glucagon
By Applications
Emergency Kits
General Use
Diagnostic and Motility
Cardiogenic Shock
Others
|
